Mmekọrịta Strategic
Teknụzụ anyị
Lifecosm Biotech Limited bụ ndị otu ndị ọkachamara rụworo ọrụ na ngalaba nke biotechnology, ọgwụ na nchọpụta microorganism pathogenic ruo ihe fọrọ nke nta ka ọ bụrụ afọ iri abụọ.Ụlọ ọrụ ahụ nwere ihe karịrị 5,000 square mita nke GMP ọkọlọtọ dị ọcha ogbako na 1S013485 àgwà usoro asambodo.Ndị otu teknụzụ nwere ahụmịhe teknụzụ bara ụba na mpaghara nchọpụta ọrịa na-efe efe na mmadụ na anụmanụ.Lifecosm ewepụtala ihe karịrị 300 ụdị mmadụ na anụmanụ reagents.
Tinyere ọrịa na-efe efe zuru ụwa ọnụ nke COVID-19, mba dị iche iche gburugburu ụwa na-agbasi mbọ ike ịchọpụta na ịchịkwa ọrịa a n'oge.Anyị ewepụtala nyocha ọhụrụ, nke nwere mmetụta dị ukwuu na nyocha serological na molecular maka nnwale nke COIVD-19.Gụnyere SARS-Cov-2-RT-PCR, SARS-CoV-2 Antigen Rapid Detection Kit, SARS-CoV-2 IgG/IgM ngwa nchọpụta ngwa ngwa, SARS-CoV-2 na Influenza A/B Virus Antigen Rapid Test Kit na COVID. -19/Flu A/Flu B/RSV/ADV Ngwa Ngwa Ngwa Ngwa Ngwakọta Antigen iji nyere ndị mmadụ aka mgbochi ọrịa Covid-19.